Drug archive
Doxorubicin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Doxorubicin (dox-oh-ROO-bi-sin) belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancers of the blood; lymph system; bladder; breast; stomach; lung; ovaries; thyroid; nerves; kidneys; bones; and soft tissues, including muscles and tendons. It may also be used to treat other kinds of cancer, as determined by your doctor.
Doxorubicin seems to interfere with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by doxorubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.
Before you begin treatment with doxorubicin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Doxorubicin is to be administered only by or under the supervision of your doctor. It is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Adriamycin PFS
- Adriamycin RDF
- Rubex
In Canada -
- Adriamycin PFS
- Adriamycin RDF
Generic name product may be available in the U.S.